Showing 2431-2440 of 2527 results for "".
- Ophthalmologists Implant First Visian Toric ICLs in the UShttps://modernod.com/news/ophthalmologists-implant-first-visian-toric-icls-in-the-us/2479710/Staar Surgical announced the first patient implants of the company’s Visian Toric Implantable Collamer Lenses (TICLs) in the United States by Brinton Vision in St. Louis and Parkhurst NuVision in San Antonio. A select group of lea
- Report: Laser Vision Correction Procedure Volume Increases for Third Straight Yearhttps://modernod.com/news/report-laser-vision-correction-procedure-volume-increases-for-third-straight-year/2479719/Laser vision correction procedure volume in the United States increased for the third year in a row, indicating a growing demand for LASIK and other laser vision correction procedures, according to data released by the Refractive Surgery Council (RSC). Year-to-date laser vision correction
- GenSight Biologics Enrolls First Subject in PIONEER Phase 1/2 Trial of Retinitis Pigmentosa Drug Candidatehttps://modernod.com/news/gensight-biologics-enrolls-first-subject-in-pioneer-phase-1-2-trial-of-retinitis-pigmentosa-drug-candidate/2479731/GenSight Biologics announced that the first subject was treated in the first-in-man PIONEER phase I/II clinical trial of GS030 at the Moorfields Eye Hospital in London, United Kingdom. “We are thrilled to see our second lead program, GS030, now entering the clinic. This is a fantastic achi
- Compact Imaging Collaborates with Novartis to Accelerate Development of Home Monitor for AMD and DRhttps://modernod.com/news/compact-imaging-collaborates-with-novartis-to-accelerate-development-of-home-monitor-for-amd-and-dr/2479735/Compact Imaging (CI), a developer of miniaturized optical coherence tomography (OCT) devices, announced the signing of a collaboration agreement with Novartis Pharma under which Novartis will fund Compact Imaging’s development of a low-cost home-based monitor to detect disease progression in adva
- LumiThera and Optos Announce Collaboration to Commercialize the Valeda Light Delivery System for Treating Dry AMD in Europehttps://modernod.com/news/lumithera-and-optos-announce-collaboration-to-commercialize-the-valeda-light-delivery-system-for-treating-dry-amd-in-europe/2479740/LumiThera announced a distribution agreement with Optos to exclusively distribute the Valeda Light Delivery System for the treatment of dry age-related macular degeneration (AMD) in 12 European countries. The announcement follows the recent CE Mark certification for the European Union (EU) for th
- Clerio Vision: First Noninvasive Laser Vision Correction Procedures Performedhttps://modernod.com/news/clerio-vision-first-noninvasive-laser-vision-correction-procedures-performed/2479743/Leveraging technology developed at the University of Rochester that was recently recognized with a Nobel Prize, Clerio Vision is commercializing LIRIC—a novel, noninvasive method to correct human vision. The core technology has been in development for more than 15 year
- New CorneaGen Interactive Education Program To Offer Free Online Training for Surgeonshttps://modernod.com/news/new-corneagen-interactive-education-program-to-offer-free-online-training-for-all-surgeons/2479755/CorneaGen is adding interactive, online courses to its free education program for surgeons around the world. Utilizing an online platform designed for universities, CorneaGen will offer instruction in cutting-edge procedures such as Nano-Thin DSEK and best practices for using transplant devices.
- IDx and Topcon Sign Exclusive AI Platform Agreement For the U.S. Markethttps://modernod.com/news/idx-and-topcon-sign-exclusive-ai-platform-agreement-for-the-u-s-market/2479766/AI diagnostics company IDx and Topcon have signed an exclusivity agreement that will allow the companies to scale delivery of AI-based diagnostic solutions in the United States. Terms of the deal were not disclosed. The agreement grants exclusive rights to IDx in the US as the only
- Oxurion Extends Partnership with Retina Global in Support of Bolivian Diabetic Retinopathy (BOLDR) Projecthttps://modernod.com/news/oxurion-extends-partnership-with-retina-global-in-support-of-bolivian-diabetic-retinopathy-boldr-project/2479770/Oxurion NV announced it is extending its partnership with Retina Global, an international nonprofit organization focused on sustainable outcomes to retinal disease management in underserved areas around the world. Oxurion will support Retina Global’s Bolivian Diabetic Retinopathy Project (BOLDR),
- Santen Announces Initiation of Phase 3 Clinical Program (SPECTRUM) Evaluating Glaucoma Treatment Omidenepag Isopropyl (DE-117)https://modernod.com/news/santen-announces-initiation-of-phase-3-clinical-development-program-spectrum-in-the-united-states-evaluating-omidenepag-isopropyl-de-117-for-the-treatment-of-glaucoma-or-ocular-hypertension/2479772/Santen announced the initiation of the pivotal phase 3 development program (SPECTRUM) in the United States, evaluating the investigational use of omidenepag isopropyl (DE-117), a selective agonist for the prostanoid receptor EP2, for the treatment of glaucoma or o